These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9549890)

  • 1. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers.
    Suzuki H; Sunada H
    Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):482-7. PubMed ID: 9549890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems.
    Suzuki H; Sunada H
    Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1688-93. PubMed ID: 9353898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation.
    Aso Y; Yoshioka S; Miyazaki T; Kawanishi T; Tanaka K; Kitamura S; Takakura A; Hayashi T; Muranushi N
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1227-31. PubMed ID: 17666850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions.
    Chavan RB; Lodagekar A; Shastri NR
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1933-1941. PubMed ID: 30102080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
    Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
    Raina SA; Alonzo DE; Zhang GG; Gao Y; Taylor LS
    Mol Pharm; 2014 Oct; 11(10):3565-76. PubMed ID: 25185035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
    Qian F; Wang J; Hartley R; Tao J; Haddadin R; Mathias N; Hussain M
    Pharm Res; 2012 Oct; 29(10):2765-76. PubMed ID: 22315020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polymer type and drug dose on the in vitro and in vivo behavior of amorphous solid dispersions.
    Knopp MM; Chourak N; Khan F; Wendelboe J; Langguth P; Rades T; Holm R
    Eur J Pharm Biopharm; 2016 Aug; 105():106-14. PubMed ID: 27212472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
    Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
    Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
    Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
    Baghel S; Cathcart H; O'Reilly NJ
    Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight.
    Vora C; Patadia R; Mittal K; Mashru R
    Pharm Dev Technol; 2016 Nov; 21(7):847-855. PubMed ID: 26333427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2015 Jan; 12(1):162-70. PubMed ID: 25426538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.